Xiaotong Jie

Dr. Xiaotong Jie


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2019 in Frontiers in Endocrinology
Verified
Journal Article
Open access
CBChe Bian
Che Bian
BBBowen Bai
Bowen Bai
QGQian Gao
Qian Gao
SLSiyi Li
Siyi Li
XJXiaotong Jie
Xiaotong Jie
Aims: To explore the molecular mechanism by which 17β-estradiol (estrogen 2, E2) regulates glucose transporter 2 (GLUT2) and insulin secretion in islet β cells through G protein-coupled estrogen receptor (GPER) via Akt/mTOR pathway. Methods: SPF-grade SD male rats were used to establish an in vivo type 2 diabetes model treated with E2. Rat insulinoma cells (INS-1) were cultured in normal or high glucose media with or without E2. Immunofluorescence double staining was used to detect GPER, GLUT2, insulin, and glucagon immunolocalization in rat islet tissues. Western blot was used to detect GPER, Akt, mTOR, and GLUT2 protein immunocontent. Real-time PCR detected Slc2a2 and glucose kinase (GK) content, and ELISA was used to detect insulin levels. Glucose uptake, GK activity and pyruvate dehydrogenase (PDH) activity were analyzed with glucose detection, GK activity and PDH activity assay kit. Results: Immunofluorescence double staining confocal indicated that E2 treatment up-regulated expression levels of GPER, GLUT2, and insulin, while down-regulated glucagon. Western blot results revealed E2 increased GPER, Akt/mTOR pathway, and GLUT2 protein immunocontent. Real-time PCR showed E2 elevated Slc2a2, GK content. Moreover, E2 improved insulin secretion, glucose uptake, GK activity, and PDH activity. Conclusion: Our findings indicated that exogenous E2 up-regulated GPER via the Akt/mTOR pathway to increase GLUT2 protein content and insulin secretion in islet β cells.

7 June 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
JWJing Wen
Jing Wen
XCXiaocen Chang
Xiaocen Chang
BBBowen Bai
Bowen Bai
QGQian Gao
Qian Gao
XJXiaotong Jie
Xiaotong Jie

4 March 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
ZXZihui Xu
Zihui Xu
XJXiaotong Jie
Xiaotong Jie
Myocardial fibrosis (MF) is a maladaptive pathological response of the heart to chronic injury. Accumulating evidence indicates that MF plays a central role in the development and progression of hypertensive heart disease, ischemic cardiomyopathy, diabetic cardiomyopathy, and heart failure, and is closely associated with an increased risk of arrhythmias and sudden cardiac death. In recent years, advances in experimental and analytical approaches have improved our understanding of the molecular mechanisms underlying MF and informed the development of potential therapeutic strategies. However, many existing pharmacological interventions exhibit limited target specificity, uncertain long-term efficacy, and incompletely defined mechanisms of action in humans. In this review, we summarize the major molecular pathways involved in myocardial fibrosis and discuss current and emerging therapeutic approaches, incorporating mechanistic insights from recent single-cell and spatial transcriptomic studies to better contextualize fibrotic signaling heterogeneity and translational challenges.

10 July 2026 in Annals of Medicine
Verified
Journal Article
Open access
PSPenghui Shi
Penghui Shi
XLXinyan Liu
Xinyan Liu
DLDanyang Li
Danyang Li
XZXinyu Zhou
Xinyu Zhou
XCXiaocen Chang
Xiaocen Chang
XJXiaotong Jie
Xiaotong Jie
1. 1.1. Sleep is a physiological process that can relieve fatigue and improve body function. It plays an important role in the normal operation of various physiological processes of the human body,...